Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,481,074
+$341,711 QoQ
Shares Held
33,394
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#1,205
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Iowa State Bank holds $35,695,888 across 7 Drug Manufacturers - General names. JNJ ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
45,266 | $11,390,736 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
33,394 | $8,481,074 | |
| 3 | LLY |
ELI LILLY & Co
|
5,120 | $6,141,082 | |
| 4 | AMGN |
Amgen Inc
|
9,653 | $3,495,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
18,782 | $2,372,917 | |
| 6 | PFE |
Pfizer Inc
|
87,501 | $2,107,024 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,634 | $1,707,511 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,481,074 | 33,394 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,139,363 | 33,298 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $7,625,279 | 36,846 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $6,921,357 | 37,328 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $6,843,200 | 44,800 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $7,478,057 | 45,092 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $6,577,028 | 45,478 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $7,411,976 | 45,736 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $6,936,899 | 47,461 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $7,474,635 | 47,251 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $7,723,520 | 49,276 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,273,298 | 40,278 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $6,309,953 | 38,122 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,028,570 | 38,894 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $7,125,888 | 40,359 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $6,613,956 | 40,487 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $7,482,756 | 42,154 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,477,687 | 42,192 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $7,220,693 | 42,209 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,149,920 | 38,080 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $6,105,757 | 37,063 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $6,153,921 | 37,444 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $6,707,849 | 42,622 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $6,286,159 | 42,223 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $5,659,935 | 40,247 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $6,413,437 | 48,909 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||